WHO 1973分级系统是T1非肌层浸润性膀胱癌的重要预后因素
该研究比较WHO 1973与2004分级系统在601例原发性T1膀胱癌中的预后价值,患者均接受卡介苗保守治疗。中位随访5.9年,WHO1973 Grade 3与无进展生存期和癌症特异性生存期显著负相关,而WHO2004分级无预后价值。多因素分析中WHO1973分级是进展的唯一预后因素。
要点
- WHO1973分级在T1膀胱癌中具有强预后价值,WHO2004分级无预后价值。
- WHO1973 Grade 3与更差的无进展生存期和癌症特异性生存期独立相关。
- 非肌层浸润性膀胱癌指南中WHO1973分级不能被WHO2004分级替代。
核心结论
- WHO1973分级系统在T1膀胱癌中具有强预后价值,优于WHO2004系统,提示指南中不能以WHO2004分级替代WHO1973分级。
研究设计与样本
- 回顾性队列研究,3名泌尿病理学家重新修订601例原发性T1膀胱癌切片,患者来自4家医院并初始接受卡介苗保守治疗。
主要发现
- 中位随访5.9年,148例进展,94例死于膀胱癌。
- WHO1973 Grade 3与无进展生存期负相关(HR 2.1)且与癌症特异性生存期负相关(HR 3.4),WHO2004分级无预后价值。
- 多因素分析中WHO1973分级是进展的唯一预后因素(HR 2.0)。
- Grade 3肿瘤(HR 3.0)、年龄较大(HR 1.03)和肿瘤大小>3 cm(HR 1.8)均与更差的癌症特异性生存期独立相关。
关键数值与推荐
- WHO1973分级:无Grade 1肿瘤,Grade 2为188例(31%),Grade 3为413例(69%)。
- WHO2004分级:低级别47例(8%),高级别554例(92%)。
临床怎么用
- 在T1非肌层浸润性膀胱癌的临床预后评估和指南制定中,应重视WHO1973分级系统,不应仅依赖WHO2004分级。
局限性
- 本研究为回顾性设计,患者均接受卡介苗保守治疗,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 classification systems for grade in T1 bladder cancer (T1-BC), as both are currently recommended in international guidelines. PATIENTS AND METHODS: Three uro-pathologists re-revised slides of 601 primary (first diagnosis) T1-BCs, initially managed conservatively (bacille Calmette-Guérin) in four hospitals. Grade was defined according to WHO1973 (Grade 1-3) and WHO2004 (low-grade [LG] and high-grade [HG]). This resulted in a lack of Grade 1 tumours, 188 (31%) Grade 2, and 413 (69%) Grade 3 tumours. There were 47 LG (8%) vs 554 (92%) HG tumours. We determined the prognostic value for progression-free survival (PFS) and cancer-specific survival (CSS) in Cox-regression models and corrected for age, sex, multiplicity, size and concomitant carcinoma in situ. RESULTS: At a median follow-up of 5.9 years, 148 patients showed progression and 94 died from BC. The WHO1973 Grade 3 was negatively associated with PFS (hazard ratio [HR] 2.1) and CSS (HR 3.4), whilst WHO2004 grade was not prognostic. On multivariable analysis, WHO1973 grade was the only prognostic factor for progression (HR 2.0). Grade 3 tumours (HR 3.0), older age (HR 1.03) and tumour size >3 cm (HR 1.8) were all independently associated with worse CSS. CONCLUSION: The WHO1973 classification system for grade has strong prognostic value in T1-BC, compared to the WHO2004 system. Our present results suggest that WHO1973 grade cannot be replaced by the WHO2004 classification in non-muscle-invasive BC guidelines.
引用
- van de Putte EEF, Bosschieter J, van der Kwast TH, et al. The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer. BJU Int. 2018. PMID: 29637669. doi:10.1111/bju.14238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。